FENC
Fennec Pharmaceuticals Inc
10.40$
+0.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -179,976,764.7% | -407,343,304.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -9,173.5% | -8,365.9% | -1,176.4% | -80.7% | 56.8% | -27.9% | |
| 7,648,382.4% | 8,368,636.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 236.5% | 9.4% | 9.7% | 1.4% | 2.0% | 0.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,641.8% | 2,361.8% | 274.9% | 25.2% | 10.6% | 15.8% | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,691.2% | 2,376.5% | 286.9% | – | – | – | |
| 51,742,205.9% | -43,794,136.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -390.0% | -81.2% | -33.2% | -38.4% | -15.4% | -33.8% | |
| 4,752,352.9% | 50,243,065.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -4,752,352.9% | -48,969,677.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 34.5% | – | – | – | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 18,993.5% | -4.7% | -12.6% | -0.4% | -0.4% | – | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2,932.9% | 2,932.9% | 1,314.2% | 23.5% | -27.3% | -43.6% | |
| 188,306,470.6% | 1,856,646,818.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 18,993.5% | 2,928.2% | 1,350.6% | 31.2% | -28.6% | 50.7% | |
| 3,577,352.9% | 1,400,333,939.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9,820.0% | -5,437.6% | 174.2% | -49.4% | 28.1% | 22.7% | |
| -184,729,117.6% | -457,586,369.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -9,173.5% | -8,365.9% | -1,176.4% | -80.7% | 56.8% | -27.9% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.